Prebiotic Galacto- and Fructo-Oligosaccharides: Health Benefits, Market Potential, and Strategies to Overcome Production Barriers

Prebiotic oligosaccharides, particularly galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), have gained considerable attention as functional food and feed ingredients due to their ability to selectively modulate the gut microbiota, enhance immune function, and promote host health. Produced enzymatically from readily available disaccharides (lactose and sucrose), these compounds offer significant commercial potential in infant nutrition, functional foods, and antibiotic-free animal production. However, their industrial-scale application remains limited by low enzymatic yields (typically 25–35%), strong product inhibition by monosaccharides, and high downstream purification costs. This review comprehensively examines the definition, health benefits, and market position of GOS and FOS, with special emphasis on the kinetic limitations of their enzymatic synthesis. Particular attention is given to integrated bioprocess strategies, including enzymatic membrane bioreactors, immobilized enzymes, and selective membrane separation technologies, which aim to reduce product inhibition and improve oligosaccharide yield and productivity. Recent advances in membrane-assisted systems have shown promising results in shifting the reaction equilibrium toward higher GOS and FOS formation. The review also discusses the role of prebiotics as sustainable alternatives to antibiotic growth promoters in poultry nutrition and analyzes the technological and economic barriers to large-scale production. In conclusion, the development of efficient, continuous, and integrated production platforms is essential to unlock the full potential of GOS and FOS. A holistic bioprocess engineering approach combining enzyme optimization, reactor design, and advanced separation technologies will be critical for meeting growing market demand and advancing sustainable nutrition solutions.